查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935245

特種注射用學名藥市場按產品類型、應用、通路和地區分類

Specialty Injectable Generics Market, By Product Type, By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2026 年，特種注射劑學名藥市場規模將達到 217.8 億美元，到 2033 年將達到 366.2 億美元，2026 年至 2033 年的複合年成長率為 7.8%。

報告內容 報告詳情
基準年： 2025 2026年市場規模： 217.8億美元
歷史數據時期： 2020年至2024年 預測期： 2026年至2033年
預測期（2026-2033年）複合年成長率： 7.80% 預計2033年價值： 366.2億美元

特殊注射藥物是高成本的藥物，必須透過注射、吸入或靜脈輸注來治療慢性或危及生命的疾病，例如 HIV、類風濕性關節炎、血友病、癌症、心血管疾病、感染疾病、自體免疫疾病和其他疾病。

市場動態

癌症和心血管疾病等慢性病的日益普及是推動特種注射劑非專利市場成長的主要因素。據美國國家癌症研究所（2013）稱，癌症根據其起源細胞類型可分為100多種類型。美國癌症協會（2017）的報告顯示，癌症是美國第二大死因，約佔所有死亡人數的四分之一。

此外，預計在不久的將來，大量醫藥和生物技術產品的專利將到期，尤其是在高價值的美國和歐洲市場，這將進一步推動市場成長。

然而，嚴格的監管準則、較低的利潤率以及藥品短缺預計將阻礙全球仿製特種注射學名藥市場的成長。該行業面臨的短缺主要源於生產問題日益增多、供應延遲以及原料藥（API）短缺。

本次調查的主要特點

  • 本報告對特種注射學名藥市場進行了詳細分析，以 2017 年為基準年，給出了預測期（2018-2026 年）內的市場規模和複合年成長率。
  • 它還重點介紹了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 該報告根據以下參數對全球特種注射學名藥市場的主要企業進行了分析：公司概況、財務業績、產品系列、市場地位、分銷策略、主要發展、戰略和未來計劃。
  • 本報告的研究結果將使負責人和經營團隊能夠就即將推出的產品、技術升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球特種注射學名藥市場報告的目標受眾是該行業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種策略矩陣輕鬆做出決策，這些矩陣用於分析特種注射用學名藥市場。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、監管與趨勢分析

  • 市場動態
    • 促進要素
    • 抑制因素
    • PEST分析
    • 波特五力分析
    • 市場機遇
    • 法規環境
    • 重大進展
    • 產業趨勢

4. 2026-2033年全球特種注射用學名藥市場（依產品類型分類）

  • 製藥
  • 生物製藥

5. 2026-2033年全球特種注射學名藥市場（依應用領域分類）

  • 腫瘤學
  • 心血管疾病
  • 中樞神經系統疾病
  • 感染疾病
  • 自體免疫疾病
  • 其他

6. 2026-2033年全球通用名學名藥市場（依通路分類）

  • 醫院藥房
  • 零售藥房
  • 網路藥房

7. 2026-2033年全球特種注射學名藥市場（依地區分類）

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析（3x3矩陣）
  • 公司簡介
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Baxter International Inc.
    • Mylan NV
    • Fresenius SE &Co. KGaA
    • Endo International Plc.
    • Hikma Pharmaceuticals PLC
    • Lupin Ltd.
    • Sagent Pharmaceuticals, Inc.
    • Cipla Limited
    • Sun Pharmaceutical Industries Limited,
    • Dr. Reddy's Laboratories

第9章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第10章各節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI1877

Specialty Injectable Generics Market is estimated to be valued at USD 21.78 Bn in 2026 and is expected to reach USD 36.62 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 21.78 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.80% 2033 Value Projection: USD 36.62 Bn

Specialty injectable is a high cost drug therapy that requires administration by injection, inhalation or infusion. This medication is indicated in treatment of chronic or life threatening diseases such as HIV, rheumatoid arthritis, hemophilia, cancer, cardiovascular diseases, infectious diseases, auto immune disorders, and other diseases.

Market Dynamics

Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases is a major factor driving the specialty injectable generics market growth. According to The National Cancer Institute, 2013, there are over 100 different types of cancers that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

Moreover, expiration of the patents of majority of pharmaceutical and biotech products in the near future, especially in high value U.S. and Europe market is boosting the market growth.

However, stringent regulatory guidelines and low profit margins and drug shortage is expected to hamper growth of the global specialty injectable generics market. The shortages faced in the industry are primarily due to increased manufacturing issues, delay in supply, and shortage of Active Pharmaceutical Ingredients (API).

Key features of the study

  • This report provides in-depth analysis of the specialty injectable generics market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global specialty injectable generics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Baxter International Inc., Mylan N.V., Fresenius SE & Co. KGaA, Endo International Plc., Hikma Pharmaceuticals PLC, Lupin Ltd., Sagent Pharmaceuticals, Inc., Cipla Limited , Sun Pharmaceutical Industries Limited, and Dr. Reddy's Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
  • The global specialty injectable generics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the specialty injectable generics market

Market Segmentation

  • By Product Type
    • Drugs
    • Biologics
  • By Application
    • Oncology
    • Cardiovascular Diseases
    • Central Nervous System Diseases
    • Infectious Diseases
    • Auto-immune Disorders
    • Others
  • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • Baxter International Inc.
    • Mylan N.V.
    • Fresenius SE & Co. KGaA
    • Endo International Plc.
    • Hikma Pharmaceuticals PLC
    • Lupin Ltd.
    • Sagent Pharmaceuticals, Inc.
    • Cipla Limited
    • Sun Pharmaceutical Industries Limited
    • Reddy's Laboratories

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Specialty Injectable Generics Market, By Product Type, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Drugs
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Biologics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Specialty Injectable Generics Market, By Application, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Cardiovascular Disease
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Central Nervous System Disease
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Infectious Disease
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Auto-immune Disorders
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Specialty Injectable Generics Market, By Distribution Channel, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospital Pharmacies
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Retail Pharmacies
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Online Pharmacies
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

7. Global Specialty Injectable Generics Market, By Region, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Pfizer, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Teva Pharmaceutical Industries Ltd.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Novartis AG
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Baxter International Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Mylan N.V.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Fresenius SE & Co. KGaA
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Endo International Plc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Hikma Pharmaceuticals PLC
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Lupin Ltd.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sagent Pharmaceuticals, Inc.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Cipla Limited
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Sun Pharmaceutical Industries Limited,
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Dr. Reddy's Laboratories
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

9. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact